Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
North America has bragging rights to the five best hospitals in the world, although institutions specifically in the United States make up only nine of the top 25.
More than 206,000 consumers enrolled in a healthcare plan during the Covid-19 special enrollment period (SEP), according to new data reported by Health Affairs.
Researchers in Italy have demonstrated a no-cost, AI-based technique for detecting the presence of previously undiagnosed abnormalities in blood sugar stability.
CVS Health, which owns health insurance giant Aetna, will return to the Obamacare marketplace to sell individual insurance plans in 2022, the company announced during a fourth-quarter earnings call.
AI can be taught to flag possible skin cancers on photos taken with smartphone cameras—and the images can be ordinary “people shots” rather than closeups of suspicious lesions.
The tool makes the call based on factors readily available to busy clinicians, respecting their workflows while helping patients and families decide whether moving to access a stepped-up care setting would fit well with their aims and values.
Two bioinformatics experts have used AI to accurately estimate regional COVID infection rates, aka seroprevalence, in all 50 states and 50 hard-hit countries.
